Sino Biological introduces AI-trusted and qualified target protein collections for AI-driven discovery

The Medical News ·
Health & Medicine United Kingdom

As AI accelerates recombinant protein and antibody discovery for therapeutic and diagnostic development, access to well-characterized target proteins is essential for evaluating AI-designed molecules.

Read original article on The Medical News →